Skip to main content

Table 2 Descriptive statistics of affected systems, MDR microorganisms and antibiotic combinations used according to the University's Antimicrobial stewardship program

From: Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care

Parameter n (%)
System affected (n=32)*
 Sputum 19 (59.3%)
 Blood 10 (31.2%)
 Urine 3 (9.4%)
Prevalence of MDR microorganisms (n=28)**
 Acinetobacter MDR 14 (50%)
 Klebsiella MDR 12 (42.8%)
 Pseudomonas MDR 2 (7.1%)
Antibiotic combinations used (n=26)  
 Piperacillin Tazobactam + Colistimethate sodium 13 (50%)
 Imipenem+ Colistimethate sodium 9 (34.6%)
 Ceftazidime-Clindamycin –Amikacin 1 (3.8%)
 Colistimethate sodium + Ciprofloxacin 1 (3.8%)
 Piperacillin + Amikacin 1 (3.8%)
 Meropenem+ Amikacin 1 (3.8%)